Key result
ABLIM1 functions as a novel oncogenic E3 ubiquitin ligase that promotes colorectal cancer growth and liver metastasis by targeting IκBα for degradation and activating the NF-κB-CCL20 signaling axis.
Answers are grounded in this paper and cite their sources.
ABLIM1 functions as a novel oncogenic E3 ligase in colorectal cancer by activating NF-ĸB signaling, highlighting a potential new therapeutic target for preventing CRC progression and metastasis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Barik et al. (2025) conducted a review in Colorectal cancer. ABLIM1 was evaluated. ABLIM1 functions as a novel oncogenic E3 ubiquitin ligase that promotes colorectal cancer growth and liver metastasis by targeting IκBα for degradation and activating the NF-κB-CCL20 signaling axis.
Synapse has enriched 10 related papers. Consider them for comparative context: